94% — What will Hims & Hers Health, Inc. say during their next earnings call
Leader: Testosterone at 94% · Kalshi 94% · 14 contracts · $3K volume · medium confidence
Updated 2026-05-09 04:21:33 UTC

Tracks the leading outcome in a winner-take-all prediction market set with 14 outcomes.

Why this matters:
This probability reflects market participants' collective assessment that peptide-related commentary will be the dominant topic during Hims & Hers Health's next earnings call, priced at 86 cents. The high confidence in peptide discussion reflects both the company's known focus on GLP-1 agonists and similar weight-loss compounds, as well as investor appetite for exposure to this market segment. Close runners-up on testosterone (83¢) and lab testing (77¢) suggest meaningful uncertainty about which product category receives emphasis. The key driver moving this probability will be management's actual statements during the earnings call itself—the timing of which depends on when Hims & Hers announces their next quarterly results. Secondary factors include recent company announcements about peptide availability, competitive developments in the telehealth weight-loss space, and any regulatory changes affecting these product categories prior to the call.

Key factors:
- Hims & Hers' peptide/GLP-1 agonist revenue and growth rate relative to other product lines in their most recent reported quarter
- Competitive activity in telehealth-delivered weight-loss medications during the period preceding the earnings call
- Recent or pending regulatory actions affecting peptide availability, compounding rules, or telehealth restrictions
- The company's stated strategic priorities in previous earnings calls and investor communications
- The specific date and timing of the next scheduled earnings announcement, which determines when resolution occurs

Contracts:
- What will Hims & Hers Health, Inc. say during their next earnings call?: Testosterone — 94¢ Kalshi $238 (weight 7%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: FDA — 86¢ Kalshi $412 (weight 12%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Peptide — 86¢ Kalshi $79 (weight 2%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Lab Testing — 84¢ Kalshi $316 (weight 10%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Canada — 78¢ Kalshi $281 (weight 8%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Zava — 74¢ Kalshi $250 (weight 8%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Collaboration — 69¢ Kalshi $710 (weight 21%)
- What will Hims & Hers Health, Inc. say during their next earnings call?: Vitamin — 50¢ Kalshi $314 (weight 9%)
- ... and 6 more

Cite as: "94% per prediction markets (SimpleFunctions, May 2026)"
Canonical: https://simplefunctions.dev/answer/earningsmentionhims
Full data: https://simplefunctions.dev/api/public/query?q=What%20will%20Hims%20%26%20Hers%20Health%2C%20Inc.%20say%20during%20their%20next%20earnings%20call
Provider: SimpleFunctions — https://simplefunctions.dev